| 1.150 -0.020 (-1.71%) 06-12 17:35 |
|
| Open: | 1.125 |
| High: | 1.155 |
| Low: | 1.100 |
| Pre. close: | 1.170 |
| Volume: | 84,231 |
| Avg. volume: | 48,615 |
| MA (50): | 1.272 |
| MA (200): | 1.463 |
| Year high: | 1.840 |
| Year low: | 1.100 |
| Market cap: | 34(M) |
| EPS: | -0.33 |
| PE ratio: | -3.48 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Thu, 11 Jun 2026
Kidney drug varoglutamstat improved eGFR in high-risk diabetics - Stock Titan
Thu, 11 Jun 2026
VVY: Strong clinical progress and reduced losses, but future hinges on new funding or partnerships - TradingView
Thu, 11 Jun 2026
Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update - GlobeNewswire
Wed, 10 Jun 2026
Vivoryon narrows Q1 loss as it advances varoglutamstat partnerships - scanx.trade
Thu, 23 Apr 2026
Vivoryon Therapeutics N.V. Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewswire
Tue, 14 Apr 2026
Drug developer Vivoryon sets April 23 webcast for 2025 results - Stock Titan
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.